Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

Medtronic Scores Regulatory Wins for PAD Balloon, Cardiac Ablation Technology

5 October 2026 · By · Wire by Fusion42

Published

5 October 2026

Topic

regulatory

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at insights.citeline.com →

◆ Verified

Fusion42 · 5 October 2026 · Fusion42 review

Medtronic has secured regulatory approvals for new devices including a peripheral artery disease (PAD) balloon and cardiac ablation technology, advancing its portfolio in cardiovascular medical devices.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You now face higher competitive pressure in cardiovascular devices as Medtronic's new FDA greenlight opens commercial doors that could shift treatment preferences and supplier relationships in cardiac ablation and PAD markets.

◆ Coverage

1 source · 5 Oct 2026

◆ Related on Wire

◆ Topics

Medtechmedtronicregulatory-approvalcardiologymedical-devicesus-fdapad-balloon